Injective vs Phantom Staked SOL Staking
Side-by-side comparison of INJ and PSOL staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Injective vs Phantom Staked SOL: which should you stake?
Phantom Staked SOL currently offers the higher APY at 6.45% compared to Injective's 6.39%. That's a 0.06 percentage point difference in annual yield.
In terms of market cap, Injective is the larger asset at $299.30M, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Injective vs Phantom Staked SOL — common questions
Is Injective or Phantom Staked SOL better for staking?
Phantom Staked SOL currently offers a higher staking APY at 6.45% compared to Injective's 6.39%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Injective and Phantom Staked SOL?
Injective offers 6.39% APY while Phantom Staked SOL offers 6.45% APY — a difference of 0.06 percentage points.
Which is safer to stake: INJ or PSOL?
Injective has a medium risk rating while Phantom Staked SOL has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both INJ and PSOL?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Injective and Phantom Staked SOL spreads your risk across different networks and protocols.